Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib.
about
Anti-tumor effects of shikonin derivatives on human medullary thyroid carcinoma cells.Cytotoxicity of the Sesquiterpene Lactones Neoambrosin and Damsin from Ambrosia maritima Against Multidrug-Resistant Cancer CellsInhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species.Natural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells.Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.Shikonin exerts antitumor activity in Burkitt's lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin.Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition.Molecular Determinants of Sensitivity or Resistance of Cancer Cells Toward Sanguinarine.Shikonin sensitizes wild‑type EGFR NSCLC cells to erlotinib and gefitinib therapyNatural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects
P2860
Q33656476-3A141CF9-74BA-4FB5-A586-4FFA7B97CBC0Q36260937-3E2A3E41-C670-4003-BF1C-EFDB58C0551FQ36629461-CD77B2F6-EC5B-425E-AB09-CF632CE1A172Q37459939-C5CC0AA8-A5D7-4D1A-A5B6-2A8B90DAF5F3Q39214221-D8BDAC90-291E-4D85-8E1E-1F35FB22B469Q48171680-024D2363-E825-4BCD-8C38-5A73F8587167Q49789609-300C5361-A959-4CEA-B07F-2C52A7DE7B0BQ52098926-BF4F0812-56D2-463A-9EF6-1BB6A91E2004Q52726755-1C476D5F-6928-4638-9BD4-E4BD1FEB5546Q58800891-50710F45-0C32-4516-9817-838D58EBDC36Q59127640-269ACF21-405B-48FE-9B26-F66399AED55A
P2860
Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Shikonin and its derivatives i ...... in combination with erlotinib.
@en
type
label
Shikonin and its derivatives i ...... in combination with erlotinib.
@en
prefLabel
Shikonin and its derivatives i ...... in combination with erlotinib.
@en
P2860
P50
P356
P1476
Shikonin and its derivatives i ...... in combination with erlotinib.
@en
P2093
Qiaoli Zhao
P2860
P304
P356
10.1002/IJC.29483
P577
2015-03-06T00:00:00Z